The minimum evidence that you have covered SCE Dermatology is not a percentage and not a completed bank. It is a checklist: even first-attempt accuracy across all fifteen blueprint domains, deliberate practice on images and therapeutics, current UK-guidance recency on the fast-moving topics, and a stable unseen mixed-block score. This article is that checklist. It is the exam-level hub for the single question "what should I study for SCE Dermatology"; platform-specific reviews should link here rather than repeat it.
The exam you are covering
The SCE in Dermatology is the standard Specialty Certificate Examination: two papers of 100 best-of-five questions — 200 in total — each three hours, one day, computer-based on Surpass, one mark per correct answer, no negative marking. It is a pure knowledge exam; there is no separate practical component within the SCE itself, though it feeds a wider certification pathway. Everything below is anchored to the authoritative MRCP(UK) blueprint, not to any vendor's topic list.
A checklist beats a study timetable here for a simple reason: a timetable tells you what to do next, but only evidence tells you whether you can stop. Two candidates can follow the same six-week plan and arrive in completely different states of readiness, because coverage is a property of what you can demonstrate, not of hours logged. The rest of this article is therefore written as things to verify, each producing a yes or a no, so that "have I covered dermatology?" becomes a question you can answer rather than a feeling you argue yourself into.
Build a blueprint coverage table
The single most useful artefact in dermatology revision is a coverage table. Give it six columns and one row per official domain: official weight, questions attempted, first-attempt accuracy, last reviewed, and confidence (high, medium, low). Populate it with your real numbers. The worked example below uses invented data for a candidate five weeks out.
| Domain | Official weight | Attempted | First-attempt accuracy | Last reviewed | Confidence |
|---|---|---|---|---|---|
| General dermatology and primary care | 48 | 220 | 74% | 6 days ago | High |
| Paediatric dermatology and genetics | 30 | 90 | 58% | 3 weeks ago | Low |
| Skin oncology | 18 | 110 | 71% | 5 days ago | High |
| Skin biology and research | 14 | 40 | 55% | 3 weeks ago | Low |
| Cutaneous allergy | 10 | 35 | 63% | 2 weeks ago | Medium |
| Dermatopathology | 10 | 25 | 48% | 4 weeks ago | Low |
| Dressings and wound care | 10 | 20 | 70% | 2 weeks ago | Medium |
| Formulation and systemic therapy | 10 | 30 | 60% | 10 days ago | Medium |
| Genito-urinary and oral medicine | 10 | 18 | 66% | 2 weeks ago | Medium |
| Infectious disease | 10 | 28 | 68% | 12 days ago | Medium |
| Skin surgery and cosmetic | 10 | 15 | 60% | 3 weeks ago | Low |
| Photodermatology | 8 | 12 | 50% | 4 weeks ago | Low |
| Dermoscopy | 4 | 10 | 40% | 4 weeks ago | Low |
| Psychodermatology | 4 | 6 | 50% | 5 weeks ago | Low |
| Skin of colour | 4 | 5 | 40% | 5 weeks ago | Low |
Read down the "last reviewed" and "confidence" columns and the plan writes itself: the low-confidence, long-since-reviewed small-count domains — dermatopathology, dermoscopy, photodermatology, skin of colour — are where marks are quietly leaking. A candidate who has done 220 general-dermatology questions and five skin-of-colour questions has not covered the blueprint, however impressive the overall percentage. This is the difference between completion and coverage.
Walk the decision tree for the worked candidate above. Her general-dermatology accuracy is high and recently reviewed, so that domain needs consolidation, not new questions. Paediatric and genetics sits at 58% and was last touched three weeks ago — a clear signal to continue new questions in a high-weight domain. Dermatopathology, dermoscopy and skin of colour are all low-confidence, low-volume and stale: these are not "do a few more questions" problems but "seek focused teaching and dedicated image practice" problems, because the underlying skill — reading a photomicrograph, recognising a dermoscopic pattern, appreciating morphology on pigmented skin — is not built by scattered questions. Her overall percentage, whatever it is, is irrelevant to any of these decisions; the table, domain by domain, has told her exactly where the next hour should go. That is the entire value of building it.
The ten domain-level blind spots most likely to stay hidden
Self-selected practice gravitates to the familiar, so these ten are the domains most often left under-tested until a real clinician reviews the plan. Before you conclude you are ready, prove you have deliberately practised each.
- Skin of colour — morphology of common conditions presents differently on pigmented skin.
- Dermoscopy — pattern recognition that browsing alone does not build.
- Dermatopathology — reading a photomicrograph is a distinct skill from clinical diagnosis.
- Photodermatology — small domain, disproportionately neglected.
- Paediatric genodermatoses — rare, examinable, easy to skip.
- Psychodermatology — often the last domain revised, if at all.
- Systemic therapeutics and monitoring — biologics and immunosuppressants, with current SmPC/eMC monitoring rules.
- Cutaneous manifestations of systemic disease — the internal-medicine overlap.
- Genito-urinary and oral mucosal disease — outside the comfort zone of skin-only revision.
- Dermatological emergencies — recognising and managing the acutely unwell skin patient.
Requiring exam-specific clinician review of the coverage table before you "sign off" is not bureaucracy; it is the most reliable way to surface a blind spot you cannot see because you have been avoiding it.
Format checklist
Verify deliberate practice on the formats that dermatology loves and text-only revision neglects: licensed clinical photographs at exam resolution, morphology description under time, dermoscopic patterns, and photomicrographs. Add the rapidly changing therapeutics — you must have practised the current indications and monitoring for systemic agents, checked against the SmPC or eMC and NICE, not a half-remembered figure. If your practice has been overwhelmingly text stems, you have a format gap regardless of your score.
Be specific about what image practice means, because passive atlas-browsing does not count. Deliberate practice is active: you look at a photograph, commit to a diagnosis and a next step before revealing the answer, and you log the misses. Do this for the presentations that dominate the blueprint — eczema and psoriasis variants, the common skin cancers and their mimics, drug eruptions, blistering disorders, the acutely erythrodermic patient — and for the same conditions on skin of colour, where the erythema you rely on may be muted, grey or violaceous rather than red. If your revision has produced a folder of conditions you can name in text but have never committed to from a picture under time, that is a measurable format gap, and it is the one dermatology punishes hardest.
Interpretation checklist
Confirm you can interpret every data type the exam can present: clinical images, dermoscopy, histopathology, laboratory trends (for example in drug monitoring or connective-tissue disease), simple therapeutic calculations, and the ethics or evidence items that appear in the "general" and research domains. A gap in any one is a predictable, avoidable loss.
Dermatopathology deserves its own line because it fails silently. A candidate who is strong clinically can assume the histology will follow, then lose a run of marks reading photomicrographs they never practised. Build a small, structured set — the common inflammatory patterns, the basal, squamous and melanocytic tumours, and the direct-immunofluorescence patterns of the immunobullous diseases — and test yourself on slides, not descriptions. The same discipline applies to laboratory trends in connective-tissue disease and to the drug-monitoring bloods for systemic agents: know not just the target value but what a drifting result should make you do.
Recency checklist
Dermatology moves quickly on therapeutics. Identify the guidance-sensitive topics — biologic and small-molecule indications, melanoma staging and management, isotretinoin governance, atopic dermatitis pathways — and record the date and jurisdiction of the source for each. UK guidance (NICE, BAD guidelines, SIGN where relevant, SmPC/eMC for drug facts) is the reference standard; an item resting on a superseded threshold or a non-UK pathway is a trap. Write the review date next to each hot topic so you can see at a glance what has gone stale.
A practical way to keep recency honest is a dated hot-list. Write the guidance-sensitive topics down the page — biologic and small-molecule eligibility, melanoma staging and sentinel-node practice, isotretinoin monitoring and governance, atopic-dermatitis stepwise therapy, and the management of severe drug reactions — and against each write the source and the date you last checked it. Anything older than a few months on a fast-moving topic goes back on the list. This takes ten minutes and prevents the specific, avoidable error of confidently choosing a drug or threshold that has since changed, which is over-represented among high-confidence mistakes.
Performance checklist
Coverage is necessary but not sufficient. Before you stop, verify: you have sat unseen, timed, mixed blocks (not just single-topic sets); your pace is comfortable at roughly 1.8 minutes per question; your high-confidence error rate — the questions you were sure of and still got wrong — is near zero; your retention holds when misses are re-tested after a delay; and your unseen scores agree with your calibration against official material. A high bank percentage with a shaky unseen mixed-block score means you are measuring recognition, which is exactly why your Q-bank percentage is not your exam score.
A useful single figure to track through the run-in is your unseen mixed-block first-attempt accuracy, plotted week on week. If it is climbing while your per-domain table fills in evenly, you are genuinely improving. If your bank percentage is high but the unseen figure lags, you are memorising a specific set of items rather than mastering the blueprint, and the fix is more unseen breadth, not more repetition of the familiar.
Stop or continue: a decision tree
Use the measured gap, not the calendar or your mood.
- If any high-weight domain is below your target first-attempt accuracy: continue new questions in that domain.
- If coverage is even but retention is poor: consolidate — stop new questions, re-test misses on a spaced schedule.
- If knowledge is solid but pacing or image speed is weak: simulate — timed full-length mixed mocks.
- If the same conceptual error recurs across domains: seek teaching on that concept rather than more questions.
- If coverage, retention, pacing and high-confidence errors are all in range: rest and taper — you are ready, and more questions add fatigue, not marks.
Your one-page checklist
Copy this and tick it before you stop doing new questions:
- All 15 blueprint domains attempted, with first-attempt accuracy recorded
- No small-count domain (dermoscopy, photodermatology, psychodermatology, skin of colour) left unpractised
- Deliberate image, dermoscopy and dermatopathology practice done
- Systemic therapeutics checked against current SmPC/eMC and NICE
- Guidance-sensitive topics dated and reviewed
- At least three unseen, timed, mixed blocks sat
- High-confidence error rate near zero
- Misses re-tested after a delay and retained
- Unseen scores agree with official-material calibration
- Coverage table reviewed by a dermatology colleague
Three mistakes candidates make with SCE Dermatology coverage
The first is mistaking a finished bank for a covered blueprint. Completing every question in one resource proves you have seen it once; it says nothing about the small-count domains that resource may barely touch. The second is over-indexing on general dermatology because it is comfortable and high-yield, while dermatopathology, dermoscopy, photodermatology and skin of colour quietly stay in the low-confidence column. Those domains carry few marks each, but together they are more than enough to decide a borderline result, and they are exactly where self-selected practice does not go. The third is trusting the overall percentage: it is inflated by re-seen questions and by your strong domains, and it hides the uneven coverage that a domain-by-domain table would expose in a minute. Every one of these is prevented by building and reviewing the coverage table honestly, with a colleague's eyes on it.
How to use this checklist with a specific resource
This hub deliberately avoids describing individual banks in detail; the platform reviews do that, and they link here so each product is held to the same standard. When you read a review of a dermatology resource — the British Association of Dermatologists' materials, a dedicated specialist bank, or a cross-specialty measurement layer — bring this checklist to it and ask the same questions: does it fill my low-confidence domains, does it give me deliberate image and therapeutics practice, is its content current, and does it move my unseen mixed-block score. A resource that improves one line of the table is worth adding; a resource that merely repeats what you already do is not, however large its question count.
Frequently asked questions
How do I know whether I have covered the full SCE Dermatology blueprint? You know when your coverage table shows every one of the fifteen domains attempted with recorded first-attempt accuracy, no small-count domain left blank, and a colleague's review has failed to find an obvious blind spot. Coverage is a property of the table, not of a completed bank; finishing every question in one resource proves only that you have seen it once.
Can one question bank be enough for SCE Dermatology? One well-constructed bank can carry the bulk of your coverage, but a single source has a single set of blind spots and a fixed house style, so relying on it alone risks training recognition of its items rather than mastery of the blueprint. Pairing a specialist bank with an unseen measurement layer is the safer configuration, which is the logic of the two-Q-bank approach.
What should I measure instead of my overall Q-bank percentage for SCE Dermatology? Measure per-domain first-attempt accuracy on unseen questions, your high-confidence error rate, retention of previously missed items after a delay, and your pacing on image-based items. These predict exam performance far better than an aggregate percentage, which is inflated by re-seen questions and by over-practising your strong domains.
When should I stop doing new SCE Dermatology questions? Stop when coverage is even across all domains, your unseen mixed-block score is stable, your high-confidence errors are near zero, and your misses are being retained on re-test. Beyond that point, additional new questions mostly add fatigue; the decision tree above points you toward consolidation, simulation, teaching or rest instead.
Which SCE Dermatology resource should I use for my weakest component? Match the resource to the weakness: for morphology and dermoscopy, use image-rich practice and the British Association of Dermatologists' resources; for dermatopathology, a structured pathology set with a reference; for therapeutics, the SmPC/eMC and NICE; and for unseen breadth and spaced retrieval across all of it, a cross-specialty measurement layer such as iatroX, which supplies fresh mixed blocks rather than a dermatology-specific bank. The principle is to stop looking for one resource that does everything and instead assign each weakness the tool built for it. A single bank rarely excels at images, histopathology and therapeutics all at once, so a small, deliberate stack — a specialist bank, the society's images, primary sources for drugs, and an unseen layer for breadth — outperforms any one product bought in the hope that it covers the lot.
Editorial notes and references
Written by Dr Kolawole Tytler, NHS GP and founder of iatroX. Last checked 21 July 2026. The worked coverage table uses invented data for illustration. Vendor-reported figures elsewhere in this series are labelled as such; verify current numbers on product pages. Disclosure: iatroX operates a UK question bank and therefore competes with some resources referenced; in this checklist its role is confined to cross-specialty unseen measurement and spaced retrieval, and it is not a specialty-specific SCE Dermatology bank. Corrections are welcome via the feedback route on iatrox.com. References: the Federation SCE Dermatology page; the British Association of Dermatologists guidelines and trainee resources; question-bank completion is not coverage; and the iatroX comparison hub.